We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $3.51B
1-Year Est. Return 13.98%
This Fund
S&P 500
This Quarter Est. Return
-0.61%
1 Year Est. Return
+13.98%
3 Year Est. Return
+39.43%
5 Year Est. Return
+43.32%
10 Year Est. Return
+133.07%
AUM
$1.1B
AUM Growth
+$99.7M
Cap. Flow
+$310M
Cap. Flow %
28.11%
Top 10 Hldgs %
54.37%
Holding
192
New
10
Increased
70
Reduced
84
Closed
9

Sector Composition

Rank Sector Weight
1 Financials 5.06%
2 Healthcare 1.94%
3 Technology 1.9%
4 Industrials 1.45%
5 Consumer Staples 1.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLRE icon
51
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.56B
$3.19M 0.29%
103,618
-173
-0.2% -$5.3K
CMCSA icon
52
Comcast
CMCSA
$85B
$3.16M 0.29%
91,524
+376
+0.4% +$12.6K
SCHW
53
Charles Schwab
SCHW
$177B
$2.94M 0.27%
74,480
-1,640
-2% -$58.6K
AMJ
54
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$2.92M 0.26%
92,230
+11,088
+14% +$339K
XOM icon
55
ExxonMobil
XOM
$611B
$2.88M 0.26%
31,867
+316
+1% +$27.6K
IWM icon
56
iShares Russell 2000 ETF
IWM
$82.2B
$2.86M 0.26%
96,954
+88,793
+1,088% +$11.3M
SCHE icon
57
Schwab Emerging Markets Equity ETF
SCHE
$12.3B
$2.82M 0.26%
130,713
-3,325
-2% -$74.4K
VYM icon
58
Vanguard High Dividend Yield ETF
VYM
$80B
$2.8M 0.25%
36,935
+4,196
+13% +$308K
USMV icon
59
iShares MSCI USA Min Vol Factor ETF
USMV
$23.1B
$2.71M 0.25%
59,971
-71
-0.1% -$3.17K
IWN icon
60
iShares Russell 2000 Value ETF
IWN
$14.4B
$2.67M 0.24%
22,406
-585
-3% -$64.7K
HYG icon
61
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.9B
$2.6M 0.24%
187,410
+181,893
+3,297% +$15.7M
MMM icon
62
3M
MMM
$83.4B
$2.59M 0.23%
17,318
-29,540
-63% -$4.26M
CVS icon
63
CVS Health
CVS
$137B
$2.55M 0.23%
32,323
-1,100
-3% -$89K
HD icon
64
Home Depot
HD
$338B
$2.53M 0.23%
18,868
+92
+0.5% +$11.9K
DHR icon
65
Danaher
DHR
$144B
$2.51M 0.23%
36,412
-1,049
-3% -$72.8K
BBH icon
66
VanEck Biotech ETF
BBH
$399M
$2.5M 0.23%
23,280
-285
-1% -$31K
VAW icon
67
Vanguard Materials ETF
VAW
$2.96B
$2.5M 0.23%
22,245
-350
-2% -$38.3K
IWF icon
68
iShares Russell 1000 Growth ETF
IWF
$123B
$2.45M 0.22%
93,312
-27,400
-23% -$711K
MSFT icon
69
Microsoft
MSFT
$2.93T
$2.12M 0.19%
34,169
-661
-2% -$39.8K
SE
70
DELISTED
Spectra Energy Corp Wi
SE
$2.12M 0.19%
51,570
-170
-0.3% -$7.04K
T icon
71
AT&T
T
$152B
$2.08M 0.19%
64,619
+159
+0.2% +$4.69K
EFV icon
72
iShares MSCI EAFE Value ETF
EFV
$26B
$2.06M 0.19%
43,524
+11,313
+35% +$526K
NEE icon
73
NextEra Energy
NEE
$185B
$2.06M 0.19%
68,836
-40,728
-37% -$1.22M
VTI icon
74
Vanguard Total Stock Market ETF
VTI
$658B
$1.97M 0.18%
17,108
-36
-0.2% -$4.05K
SLB icon
75
SLB Ltd
SLB
$70.3B
$1.96M 0.18%
23,387
+195
+0.8% +$16K

Similar funds

Aspiriant LLC's Q4 2016 Portfolio in Review

As of Q4 2016, Aspiriant LLC held 192 positions worth $1.1B, up 9.9% from $1B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Aspiriant LLC deployed $310M of net new capital in Q4 2016, opening 10 new positions and adding to 70 existing holdings. Its largest new stake was Meta Platforms (Facebook): 12,760 shares worth $1.47M.

By sector, the portfolio is most concentrated in Financials at 5.1% of assets, down from 5.5% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was State Street SPDR Dow Jones International Real Estate ETF, an estimated $44.8M trimmed.

  • Aspiriant LLC's largest Q4 2016 buy was Meta Platforms (Facebook): 12,760 shares worth $1.47M.
  • Aspiriant LLC added most to iShares National Muni Bond ETF in Q4 2016, an estimated $111M increase.
  • Aspiriant LLC's biggest Q4 2016 reduction was State Street SPDR Dow Jones International Real Estate ETF, cutting an estimated $44.8M.
  • Aspiriant LLC fully exited WisdomTree Europe Hedged Equity Fund in Q4 2016, selling an estimated $1.98M.
  • Aspiriant LLC's ten largest holdings make up 54% of its $1.1B portfolio in Q4 2016.
  • Aspiriant LLC opened 10 new positions and closed 9 in Q4 2016.
  • Aspiriant LLC's portfolio value rose 9.9% quarter-over-quarter to $1.1B.

Based on Aspiriant LLC's 13F filing for Q4 2016, filed 10 Feb 2017.